Targeting atherosclerosis with antihypertensive therapy

Affiliations

¹ Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON, K1Y 4W7, Canada. TRuddy@ottawaheart.ca.
² Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON, K1Y 4W7, Canada.

Editorial

Terrence D Ruddy et al. J Nucl Cardiol. 2023 Aug.

. 2023 Aug;30(4):1627-1629.

doi: 10.1007/s12350-023-03272-w. Epub 2023 May 3.

¹ Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON, K1Y 4W7, Canada. TRuddy@ottawaheart.ca.
² Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON, K1Y 4W7, Canada.

No abstract available

Comment on

Effects of olmesartan and amlodipine on blood pressure, endothelial function, and vascular inflammation.
Honda A, Tahara N, Tahara A, Bekki M, Maeda-Ogata S, Sugiyama Y, Igata S, Nishino Y, Matsui T, Kurata S, Abe T, Yamagishi SI, Fukumoto Y. Honda A, et al. J Nucl Cardiol. 2023 Aug;30(4):1613-1626. doi: 10.1007/s12350-023-03200-y. Epub 2023 Feb 3. J Nucl Cardiol. 2023. PMID: 36737518 Clinical Trial.

1. Whelton P, Carey R, Aronow W, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol 2018;71:e127‐248. - DOI - PubMed
1. Williams B, Mancia G, Spiering W, et al. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018;39:3021‐104. - DOI - PubMed
1. Xu C, Li M, Meng W, et al. Etiological diagnosis and personalized therapy for hypertension: A hypothesis of the REASOH classification. J Pers Med 2023;13:261. - DOI - PubMed - PMC
1. Raghubeer S. The influence of epigenetics and inflammation on cardiometabolic risks. Semin Cell Dev Biol 2023;15:S1084-9521.
1. Libby P. Inflammation during the life cycle of the atherosclerotic plaque. Cardiovasc Res 2021;117:2525‐36. - PubMed - PMC